Merit CRO
Private Company
Funding information not available
Overview
MERIT CRO is a private, revenue-generating services company founded in 2003, headquartered in Madison, Wisconsin, USA. It has established itself as a specialized endpoint expert, providing critical imaging and assessment services for global clinical trials, with a proven track record serving 13 of the top 20 global pharma companies. The company's growth is underscored by its inclusion on the Inc. 5000 list for eight consecutive years and its strategic acquisition of OSOD to expand into preclinical research. MERIT's business model is built on deep therapeutic area expertise, a standardized operational approach, and its proprietary EXCELSIOR™ software platform.
Technology Platform
EXCELSIOR™, a comprehensive, cloud-based software platform providing a suite of advanced endpoint analysis tools, real-time sponsor access, and standardized workflows for site certification, data management, reader monitoring, and output.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
MERIT competes with other specialized imaging and endpoint CROs (e.g., BioClinica, ICON's Medical Imaging division, Calyx) and the central lab divisions of large, full-service CROs. Its differentiators are its focused therapeutic expertise, proprietary EXCELSIOR™ platform, and integrated preclinical/clinical services.